KKR x Tina’s Wish Lunch & Learn
On May 27th, Tina's Wish partnered with KKR to host a fireside chat exploring the critical role of genetic testing in ovarian... View more
MIO Partners x Tina’s Wish Lunch & Learn
On May 13th, Tina's Wish partnered with MIO Partners to host "Coffee with a Cause" — a meaningful gathering to champion advocacy,... View more
TINA’S WISH AND RISING STAR GRANTEE DR. SARAH HILL FEATURED IN IMPACT SUMMER 2020
“Almost 80% of women with ovarian cancer are diagnosed at an advanced stage, when there is a diminished chance for a cure,… View more
TINA’S WISH RESEARCHER DR. SAMUEL MOK RECOGNIZED IN TREATMENT BREAKTHROUGH
“Scientists have created a promising new way to treat late-stage ovarian and pancreatic cancers. The cancers are two of the most lethal… View more
TINA’S WISH AWARDS DANA-FARBER CANCER INSTITUTE WITH $200K GRANT IN SUPPORT OF EARLY DETECTION OVARIAN CANCER RESEARCH
Tina’s Wish awarded Dana-Farber Cancer Institute with a $200,000 grant in support of Dr. Dipanjan Chowdhury’s research, which is focused on developing… View more
TINA’S WISH RESEARCHER DR. SIMON GAYTHER PUBLISHES PAPER ON NEWLY IDENTIFIED GENES associated with an increased risk for ovarian cancer
“A team of researchers at UCLA’s Jonsson Comprehensive Cancer, Cedars-Sinai Cancer and Dana-Farber Cancer Institute have newly identified 34 genes that are… View more